Published February 9, 2022 | Version 1
Journal article Open

Pre-2019 Antarctic specimens with SARS-CoV-2 sequences found in Hefei, China laboratories are likely contamination from local COVID-19 specimens from Jan 2020 and later

  • 1. Atossa Therapeutics, Inc.

Description

SARS-CoV-2 genome sequences identified in specimens collected in the Antarctica before 2019 have a three SNV signature also found uniquely in clinical COVID specimens from early 2020 from Hefei Province, China and are most likely simple clinical lab-research lab cross contamination.

Files

Reanalysis of SARS-CoV-2 sequences in Antartic specimens from before 2019 have a mutation signature of clinical COVID cases.pdf